Table of Content

"1    INTRODUCTION    30
1.1    OBJECTIVES OF THE STUDY    30
1.2    MARKET DEFINITION    30
1.2.1    INCLUSIONS & EXCLUSIONS OF THE STUDY    31
1.3    MARKET SCOPE    32
1.3.1    MARKETS COVERED    32
FIGURE 1    METAGENOMIC SEQUENCING MARKET SEGMENTATION    32
1.3.2    YEARS CONSIDERED FOR THE STUDY    33
1.4    CURRENCY    33
1.5    LIMITATIONS    33
1.6    STAKEHOLDERS    34
1.7    SUMMARY OF CHANGES    34
2    RESEARCH METHODOLOGY    35
2.1    RESEARCH DATA    35
FIGURE 2    RESEARCH DESIGN    35
2.1.1    SECONDARY DATA    36
2.1.2    PRIMARY DATA    37
FIGURE 3    PRIMARY SOURCES    37
FIGURE 4    METAGENOMIC SEQUENCING MARKET: BREAKDOWN OF PRIMARIES    38
2.1.2.1    Key industry insights    39
2.2    MARKET SIZE ESTIMATION    39
FIGURE 5    MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2021    39
FIGURE 6    MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP (SUPPLY SIDE) – COLLECTIVE REVENUE OF ALL METAGENOMIC SEQUENCING
PRODUCTS & SERVICES    40
FIGURE 7    METAGENOMIC SEQUENCING MARKET: CAGR PROJECTIONS, 2022–2027    42
FIGURE 8    METAGENOMIC SEQUENCING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    42
2.3    MARKET BREAKDOWN AND DATA TRIANGULATION    44
FIGURE 9    DATA TRIANGULATION METHODOLOGY    44
2.4    RESEARCH LIMITATIONS    45
2.5    GROWTH RATE ASSUMPTIONS    45
2.6    RISK ANALYSIS    45

3    EXECUTIVE SUMMARY    46
FIGURE 10    METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE,
2022 VS. 2027 (USD MILLION)    46
FIGURE 11    METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021    47
FIGURE 12    METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION)    48
FIGURE 13    METAGENOMIC SEQUENCING MARKET SHARE, BY TECHNOLOGY, 2021    49
FIGURE 14    GEOGRAPHICAL SNAPSHOT OF THE METAGENOMIC SEQUENCING MARKET    50
4    PREMIUM INSIGHTS    51
4.1    METAGENOMIC SEQUENCING MARKET OVERVIEW    51
FIGURE 15    TECHNOLOGICAL INNOVATIONS IN NGS PLATFORMS—A KEY FACTOR DRIVING GROWTH IN THE METAGENOMIC SEQUENCING MARKET    51
4.2    ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY
& COUNTRY (2021)    52
FIGURE 16    16S RRNA SEQUENCING TECHNOLOGY ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021    52
4.3    METAGENOMIC SEQUENCING MARKET SHARE FOR INDUSTRIAL APPLICATIONS,
BY TYPE, 2021    53
FIGURE 17    ENERGY APPLICATION SEGMENT DOMINATED THE MARKET IN 2021    53
5    MARKET OVERVIEW    54
5.1    INTRODUCTION    54
5.2    MARKET DYNAMICS    54
FIGURE 18    METAGENOMIC SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    54
5.2.1    DRIVERS    55
5.2.1.1    Continuous technological innovations in NGS platforms    55
5.2.1.1.1    iSeq 100 System    55
5.2.1.1.2    Ion GeneStudio S5    55
5.2.1.2    Initiatives and funding from government & private bodies for large-scale sequencing projects    55
TABLE 1    GLOBAL SEQUENCING INITIATIVES    56
5.2.1.3    Declining costs of genome sequencing    57
FIGURE 19    COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2020    57
5.2.1.4    Significant applications of metagenomics in various fields    57
5.2.2    RESTRAINTS    58
5.2.2.1    End-user budget constraints in developing countries    58
5.2.3    OPPORTUNITIES    59
5.2.3.1    NGS data analysis using big data    59
FIGURE 20    DATA PRODUCTION DURING HUMAN WHOLE-GENOME SEQUENCING,
2001–2019    59
5.2.4    CHALLENGES    60
5.2.4.1    Challenges associated with metagenomic NGS    60
5.3    IMPACT OF COVID-19 ON THE METAGENOMIC SEQUENCING MARKET    61
5.4    PORTER’S FIVE FORCES ANALYSIS    63
TABLE 2    METAGENOMIC SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS    63
5.4.1    THREAT OF NEW ENTRANTS    63
5.4.2    THREAT OF SUBSTITUTES    63
5.4.3    BARGAINING POWER OF SUPPLIERS    63
5.4.4    BARGAINING POWER OF BUYERS    63
5.4.5    COMPETITIVE RIVALRY AMONG EXISTING PLAYERS    64
5.5    VALUE CHAIN ANALYSIS    64
FIGURE 21    VALUE CHAIN ANALYSIS OF THE METAGENOMIC SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE    64
FIGURE 22    VALUE CHAIN: METAGENOMIC SEQUENCING ANALYSIS WORKFLOW —MAXIMUM VALUE IS ADDED DURING THE SEQUENCING AND
ANALYSIS PHASES    65
5.6    ECOSYSTEM ANALYSIS    66
FIGURE 23    ECOSYSTEM ANALYSIS: METAGENOMIC SEQUENCING MARKET    66
TABLE 3    SUPPLY CHAIN ECOSYSTEM    66
5.7    PATENT ANALYSIS    67
5.7.1    TOP 10 GRANTED PATENT OWNERS IN THE LAST 20 YEARS    67
5.7.2    TOP 10 PLAYERS WITH THE HIGHEST NO. OF PATENT APPLICATIONS    68
5.7.3    LIST OF RECENT PATENTS    68
5.8    SUPPLY CHAIN ANALYSIS    69
FIGURE 24    DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR PROMINENT COMPANIES    70
5.9    REGULATORY ANALYSIS    70
5.9.1    NORTH AMERICA    70
5.9.1.1    US    70
TABLE 4    US FDA: MEDICAL DEVICE CLASSIFICATION    71
TABLE 5    US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS    71
5.9.1.2    Canada    72
5.9.2    EUROPE    72
5.9.3    ASIA PACIFIC    73
5.9.3.1    China    73
TABLE 6    CHINA: CLASSIFICATION OF MEDICAL DEVICES    73
5.9.3.2    Japan    73
5.9.3.3    India    73
5.9.4    LATIN AMERICA    74
5.9.5    MIDDLE EAST    74
5.10    PRICING ANALYSIS    74
TABLE 7    AVERAGE SELLING PRICE OF NGS SYSTEMS (2020)    74
5.11    RANGES/SCENARIOS    75
FIGURE 25    DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE METAGENOMIC SEQUENCING MARKET    75
5.12    TRADE ANALYSIS    75
5.12.1    TRADE ANALYSIS FOR METAGENOMIC SEQUENCING MARKET    75
TABLE 8    IMPORT DATA FOR HS CODE 902780, BY COUNTRY,
2016-2020 (USD THOUSAND)    75
TABLE 9    EXPORT DATA FOR HS CODE 902780, BY COUNTRY,
2016-2020 (USD THOUSAND)    76
5.13    TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS    76
5.14    KEY CONFERENCES & EVENTS, 2022    77
TABLE 10    METAGENOMIC SEQUENCING MARKET: DETAILED LIST OF CONFERENCES & EVENTS    77
5.15    KEY STAKEHOLDERS & BUYING CRITERIA    78
TABLE 11    INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP THREE APPLICATIONS (%)    78
TABLE 12    KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS    78
6    METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE    79
6.1    INTRODUCTION    80
TABLE 13    METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION)    80
6.2    REAGENTS & CONSUMABLES    80
6.2.1    RISING ADOPTION OF METAGENOMIC SEQUENCING IS DRIVING
THE USE OF REAGENTS & CONSUMABLES    80
TABLE 14    METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET,
 BY REGION, 2020–2027 (USD MILLION)    81
TABLE 15    NORTH AMERICA: METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    81
TABLE 16    EUROPE: METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    81
TABLE 17    APAC: METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    82
6.3    INSTRUMENTS    82
6.3.1    LAUNCH OF ADVANCED NGS PLATFORMS WILL SUPPORT
THE GROWTH OF THIS SEGMENT    82
TABLE 18    METAGENOMIC SEQUENCING INSTRUMENTS MARKET, BY REGION,
 2020–2027 (USD MILLION)    83
TABLE 19    NORTH AMERICA: METAGENOMIC SEQUENCING INSTRUMENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)    83
TABLE 20    EUROPE: METAGENOMIC SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    83
TABLE 21    APAC: METAGENOMIC SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    84
6.4    SERVICES    84
6.4.1    TIME AND COST-EFFECTIVENESS OF OUTSOURCING NGS PROJECTS HAS DRIVEN THE DEMAND FOR SERVICES    84
TABLE 22    METAGENOMIC SEQUENCING SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION)    84
TABLE 23    NORTH AMERICA: METAGENOMIC SEQUENCING SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)    85
TABLE 24    EUROPE: METAGENOMIC SEQUENCING SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)    85
TABLE 25    APAC: METAGENOMIC SEQUENCING SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)    85
6.5    ANALYSIS & DATA INTERPRETATION SOLUTIONS    86
6.5.1    LIMITED TECHNICAL KNOWLEDGE OF ADVANCED ANALYSIS SOLUTIONS AMONG END USERS TO HAMPER MARKET GROWTH    86
TABLE 26    METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)    86
TABLE 27    NORTH AMERICA: METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    86
TABLE 28    EUROPE: METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    87
TABLE 29    APAC: METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    87
7    METAGENOMIC SEQUENCING MARKET, BY WORKFLOW    88
7.1    INTRODUCTION    89
TABLE 30    METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)    89
7.2    SAMPLE PROCESSING & LIBRARY PREPARATION    89
7.2.1    AVAILABILITY OF TECHNOLOGICALLY ADVANCED SAMPLE PROCESSING AND LIBRARY PREPARATION ASSAY KITS IS DRIVING MARKET GROWTH    89
TABLE 31    SAMPLE PROCESSING & LIBRARY PREPARATION MARKET, BY REGION, 2020–2027 (USD MILLION)    90
TABLE 32    NORTH AMERICA: SAMPLE PROCESSING & LIBRARY PREPARATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    90
TABLE 33    EUROPE: SAMPLE PROCESSING & LIBRARY PREPARATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)    91
TABLE 34    APAC: SAMPLE PROCESSING & LIBRARY PREPARATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)    91
7.3    SEQUENCING    91
7.3.1    SANGER SEQUENCING HAS BEEN SUPPLANTED BY NGS DUE TO ITS ADVANTAGES AND RAPIDITY    91
TABLE 35    SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)    92
TABLE 36    NORTH AMERICA: SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    92
TABLE 37    EUROPE: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    92
TABLE 38    APAC: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    93
7.4    DATA PROCESSING & ANALYSIS    93
7.4.1    NEED FOR SKILLED PERSONNEL TO OPERATE DATA PROCESSING AND ANALYTICS TOOLS HAS SLOWED MARKET GROWTH    93
TABLE 39    DATA PROCESSING & ANALYSIS MARKET, BY REGION,
2020–2027 (USD MILLION)    94
TABLE 40    NORTH AMERICA: DATA PROCESSING & ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    94
TABLE 41    EUROPE: DATA PROCESSING & ANALYSIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    94
TABLE 42    APAC: DATA PROCESSING & ANALYSIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    95
8    METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY    96
8.1    INTRODUCTION    97
TABLE 43    METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    97
8.2    16S RRNA SEQUENCING    97
8.2.1    16S RRNA SEQUENCING IS A COST-EFFECTIVE TECHNIQUE FOR THE IDENTIFICATION OF BACTERIAL STRAINS    97
TABLE 44    16S RRNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)    98
TABLE 45    NORTH AMERICA: 16S RRNA SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    98
TABLE 46    EUROPE: 16S RRNA SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    99
TABLE 47    APAC: 16S RRNA SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    99
8.3    SHOTGUN METAGENOMIC SEQUENCING    99
8.3.1    SHOTGUN METAGENOMIC SEQUENCING SEGMENT TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD    99
TABLE 48    SHOTGUN METAGENOMIC SEQUENCING MARKET, BY REGION,
2020–2027 (USD MILLION)    100
TABLE 49    NORTH AMERICA: SHOTGUN METAGENOMIC SEQUENCING MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)    100
TABLE 50    EUROPE: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    101
TABLE 51    APAC: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    101
8.4    WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY    101
8.4.1    WGS HELPS GENERATE ACCURATE REFERENCE GENOMES FOR MICROBIAL IDENTIFICATION    101
TABLE 52    WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY REGION, 2020–2027 (USD MILLION)    102
TABLE 53    NORTH AMERICA: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    102
TABLE 54    EUROPE: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)    103
TABLE 55    APAC: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)    103
8.5    METATRANSCRIPTOMICS    103
8.5.1    METATRANSCRIPTOMICS HELPS IN THE UNDERSTANDING OF THE ACTIVE FUNCTIONAL PROFILE OF A MICROBIAL COMMUNITY    103
TABLE 56    METATRANSCRIPTOMICS MARKET, BY REGION, 2020–2027 (USD MILLION)    104
TABLE 57    NORTH AMERICA: METATRANSCRIPTOMICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    105
TABLE 58    EUROPE: METATRANSCRIPTOMICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    105
TABLE 59    APAC: METATRANSCRIPTOMICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    105
9    METAGENOMIC SEQUENCING MARKET, BY APPLICATION    106
9.1    INTRODUCTION    107
TABLE 60    METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    107
9.2    DRUG DISCOVERY    107
9.2.1    DRUG DISCOVERY ACCOUNTS FOR THE LARGEST SHARE OF THE METAGENOMIC SEQUENCING MARKET    107
TABLE 61    METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY, BY REGION, 2020–2027 (USD MILLION)    108
TABLE 62    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2020–2027 (USD MILLION)    108
TABLE 63    EUROPE: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2020–2027 (USD MILLION)    108
TABLE 64    APAC: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2020–2027 (USD MILLION)    109
9.3    CLINICAL DIAGNOSTICS    109
9.3.1    ADVANTAGES OF METAGENOMIC NGS HAVE ENABLED WIDE APPLICATIONS IN DIAGNOSTICS    109
TABLE 65    METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS,
BY REGION, 2020–2027 (USD MILLION)    110
TABLE 66    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)    110
TABLE 67    EUROPE: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)    110
TABLE 68    APAC: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)    111
9.4    SOIL MICROBIOME APPLICATIONS    111
9.4.1    NORTH AMERICA SHOWS HIGH DEMAND FOR METAGENOMIC SEQUENCING IN SOIL MICROBIOME APPLICATIONS    111
TABLE 69    METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)    111
TABLE 70    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    112
TABLE 71    EUROPE: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    112
TABLE 72    APAC: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    112

9.5    INDUSTRIAL APPLICATIONS    113
TABLE 73    METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION)    113
TABLE 74    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    113
TABLE 75    EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    114
TABLE 76    APAC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    114
TABLE 77    METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS,
BY TYPE, 2020–2027 (USD MILLION)    114
9.5.1    ENERGY    115
9.5.1.1    Declining fossil fuel reserves and growing energy needs will drive market growth    115
TABLE 78    METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION)    115
TABLE 79    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    115
TABLE 80    EUROPE: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    116
TABLE 81    APAC: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    116
9.5.2    BIOREMEDIATION    116
9.5.2.1    Need to monitor pollutant impact and contamination will provide opportunities for metagenomic sequencing in bioremediation    116
TABLE 82    METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION, BY REGION, 2020–2027 (USD MILLION)    117
TABLE 83    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION, BY COUNTRY, 2020–2027 (USD MILLION)    117
TABLE 84    EUROPE: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION,
BY COUNTRY, 2020–2027 (USD MILLION)    117
TABLE 85    APAC: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION,
BY COUNTRY, 2020–2027 (USD MILLION)    118
9.5.3    OTHER INDUSTRIAL APPLICATIONS    118
TABLE 86    METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)    118
TABLE 87    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    119
TABLE 88    EUROPE: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    119
TABLE 89    APAC: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    119
9.6    ECOLOGICAL & ENVIRONMENTAL APPLICATIONS    120
9.6.1    METAGENOMIC SEQUENCING CAN HELP IDENTIFY INVASIVE AND ENDANGERED SPECIES    120
TABLE 90    METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)    120
TABLE 91    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    120
TABLE 92    EUROPE: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    121
TABLE 93    APAC: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    121
9.7    VETERINARY APPLICATIONS    121
9.7.1    DEMAND FOR RAPID AND ACCURATE PATHOGEN DIAGNOSIS IS SUPPORTING THE DEMAND FOR SEQUENCING    121
TABLE 94    METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION)    122
TABLE 95    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    122
TABLE 96    EUROPE: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    122
TABLE 97    APAC: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    123
9.8    OTHER APPLICATIONS    123
TABLE 98    METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION)    123
TABLE 99    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    124
TABLE 100    EUROPE: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    124
TABLE 101    APAC: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION)    124
10    METAGENOMIC SEQUENCING MARKET, BY REGION    125
10.1    INTRODUCTION    126
TABLE 102    METAGENOMIC SEQUENCING MARKET, BY REGION,
2020–2027 (USD MILLION)    126
10.2    NORTH AMERICA    126
FIGURE 26    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET SNAPSHOT    127
TABLE 103    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)    128
TABLE 104    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)    128
TABLE 105    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)    128
TABLE 106    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)    129
TABLE 107    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)    129
TABLE 108    NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    130
10.2.1    US    130
10.2.1.1    Well-established infrastructure and funding sources available for NGS-based small- and medium-sized research projects make the US the largest market in North America    130
TABLE 109    US: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)    131
TABLE 110    US: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION)    131
TABLE 111    US: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    132
TABLE 112    US: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    132
TABLE 113    US: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    132
10.2.2    CANADA    133
10.2.2.1    Increasing government initiatives and workshops to support growth in this market    133
TABLE 114    CANADA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)    133
TABLE 115    CANADA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)    134
TABLE 116    CANADA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    134
TABLE 117    CANADA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    135
TABLE 118    CANADA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    135
10.3    EUROPE    135
TABLE 119    EUROPE: METAGENOMIC SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    136
TABLE 120    EUROPE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)    136
TABLE 121    EUROPE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)    137
TABLE 122    EUROPE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    137
TABLE 123    EUROPE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    138
TABLE 124    EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    138
10.3.1    GERMANY    139
10.3.1.1    Germany has witnessed a significant increase in investments in next-generation technologies, making it the largest market in Europe    139
TABLE 125    GERMANY: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)    140
TABLE 126    GERMANY: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)    140
TABLE 127    GERMANY: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    140
TABLE 128    GERMANY: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    141
TABLE 129    GERMANY: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    141
10.3.2    FRANCE    141
10.3.2.1    Government initiatives to support genomics research drive growth in the metagenomic sequencing market in France    141
TABLE 130    FRANCE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)    142
TABLE 131    FRANCE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)    142
TABLE 132    FRANCE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    143
TABLE 133    FRANCE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    143
TABLE 134    FRANCE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    144
10.3.3    UK    144
10.3.3.1    Favorable funding scenario for genomics research in the country to support the adoption of NGS    144
TABLE 135    UK: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)    145
TABLE 136    UK: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION)    145
TABLE 137    UK: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    146
TABLE 138    UK: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    146
TABLE 139    UK: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    146
10.3.4    REST OF EUROPE    147
TABLE 140    ROE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)    147
TABLE 141    ROE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)    148
TABLE 142    ROE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    148
TABLE 143    ROE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
 2020–2027 (USD MILLION)    149
TABLE 144    ROE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    149
10.4    ASIA PACIFIC    149
FIGURE 27    ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET SNAPSHOT    150
TABLE 145    ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    151
TABLE 146    ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)    151
TABLE 147    ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)    151
TABLE 148    ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)    152
TABLE 149    ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)    152
TABLE 150    ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    153
10.4.1    CHINA    153
10.4.1.1    Several key market players are focusing on strengthening their presence and offerings in China—a key factor driving market growth    153
TABLE 151    CHINA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)    154
TABLE 152    CHINA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)    154
TABLE 153    CHINA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    155
TABLE 154    CHINA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    155
TABLE 155    CHINA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    156
10.4.2    JAPAN    156
10.4.2.1    Rising use of metagenomic sequencing for various applications to drive market growth in Japan    156
TABLE 156    JAPAN: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)    157
TABLE 157    JAPAN: METAGENOMIC SEQUENCING MARKET, BY PRODUCT &
SERVICE, 2020–2027 (USD MILLION)    157
TABLE 158    JAPAN: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    158
TABLE 159    JAPAN: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    158
TABLE 160    JAPAN: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    159
10.4.3    INDIA    159
10.4.3.1    Increasing adoption of strategies such as collaborations and partnerships by various private and government bodies to drive market growth    159
TABLE 161    INDIA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
 2020–2027 (USD MILLION)    160
TABLE 162    INDIA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)    160
TABLE 163    INDIA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    161
TABLE 164    INDIA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    161
TABLE 165    INDIA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    162
10.4.4    REST OF ASIA PACIFIC    162
TABLE 166    ROAPAC: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)    163
TABLE 167    ROAPAC: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)    163
TABLE 168    ROAPAC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    163
TABLE 169    ROAPAC: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    164
TABLE 170    ROAPAC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    164
10.4.5    LATIN AMERICA    164
10.4.5.1    Introduction of low-cost sequencing technologies is expected to drive the market    164
TABLE 171    LATAM: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)    165
TABLE 172    LATAM: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)    165
TABLE 173    LATAM: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    166
TABLE 174    LATAM: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    166
TABLE 175    LATAM: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    167
10.4.6    MIDDLE EAST & AFRICA    167
10.4.6.1    Rising awareness of advanced sequencing technologies is expected to drive market growth in the coming years    167
TABLE 176    MEA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)    167
TABLE 177    MEA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)    168
TABLE 178    MEA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)    168
TABLE 179    MEA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    169
TABLE 180    MEA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)    169
11    COMPETITIVE LANDSCAPE    170
11.1    KEY PLAYER STRATEGIES    170
FIGURE 28    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE METAGENOMIC SEQUENCING MARKET    171
11.2    MARKET SHARE ANALYSIS    172
FIGURE 29    METAGENOMIC SEQUENCING MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2020    172
TABLE 181    METAGENOMIC SEQUENCING MARKET: DEGREE OF COMPETITION    172
11.3    REVENUE ANALYSIS    173
FIGURE 30    REVENUE ANALYSIS FOR KEY COMPANIES (2018-2021)    173
11.4    COMPANY EVALUATION QUADRANT    174
FIGURE 31    METAGENOMIC SEQUENCING MARKET: COMPANY EVALUATION MATRIX, 2021    174
11.4.1    STARS    175
11.4.2    PERVASIVE PLAYERS    175
11.4.3    EMERGING LEADERS    175
11.4.4    PARTICIPANTS    175
11.5    COMPETITIVE LEADERSHIP MAPPING (START-UPS)    176
FIGURE 32    METAGENOMIC SEQUENCING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS, 2021    176
11.5.1    PROGRESSIVE COMPANIES    177
11.5.2    STARTING BLOCKS    177
11.5.3    DYNAMIC COMPANIES    177
11.5.4    RESPONSIVE COMPANIES    177
11.6    COMPETITIVE BENCHMARKING    177
TABLE 182    COMPANY PRODUCT FOOTPRINT (25 COMPANIES)    177
TABLE 183    COMPANY REGION FOOTPRINT (25 COMPANIES)    178
11.7    COMPETITIVE SCENARIO    179
11.7.1    PRODUCT LAUNCHES    179
TABLE 184    METAGENOMIC SEQUENCING MARKET: PRODUCT LAUNCHES,
JANUARY 2018-FEBRUARY 2022    179
11.7.2    DEALS    180
TABLE 185    METAGENOMIC SEQUENCING MARKET: DEALS,
JANUARY 2018-FEBRUARY 2022    180
11.7.3    OTHER DEVELOPMENTS    181
TABLE 186    METAGENOMIC SEQUENCING MARKET: OTHER DEVELOPMENTS,
 JANUARY 2018-FEBRUARY 2022    181
12    COMPANY PROFILES    182
12.1    MAJOR PLAYERS    182
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1    ILLUMINA, INC.    182
TABLE 187    ILLUMINA, INC.: BUSINESS OVERVIEW    182
FIGURE 33    ILLUMINA, INC.: COMPANY SNAPSHOT (2021)    183
12.1.2    THERMO FISHER SCIENTIFIC, INC.    188
TABLE 188    THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW    188
FIGURE 34    THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)    189
12.1.3    QIAGEN N.V.    194
TABLE 189    QIAGEN N.V.: BUSINESS OVERVIEW    194
FIGURE 35    QIAGEN N.V.: COMPANY SNAPSHOT (2020)    195
12.1.4    PERKINELMER, INC.    200
TABLE 190    PERKINELMER, INC.: BUSINESS OVERVIEW    200
FIGURE 36    PERKINELMER, INC.: COMPANY SNAPSHOT (2021)    201
12.1.5    OXFORD NANOPORE TECHNOLOGIES, PLC.    204
TABLE 191    OXFORD NANOPORE TECHNOLOGIES, PLC.: BUSINESS OVERVIEW    204
12.1.6    PACIFIC BIOSCIENCES OF CALIFORNIA, INC.    207
TABLE 192    PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: BUSINESS OVERVIEW    207
FIGURE 37    PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT (2020)    208
12.1.7    BGI GROUP    212
TABLE 193    BGI GROUP: BUSINESS OVERVIEW    212
12.1.8    PSOMAGEN, INC.    215
TABLE 194    PSOMAGEN, INC.: BUSINESS OVERVIEW    215
12.1.9    EUROFINS SCIENTIFIC    217
TABLE 195    EUROFINS SCIENTIFIC: BUSINESS OVERVIEW    217
FIGURE 38    EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020)    218
12.1.10    BROOKS AUTOMATION, INC.    220
TABLE 196    BROOKS AUTOMATION, INC.: BUSINESS OVERVIEW    220
FIGURE 39    BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2020)    221
12.1.11    NOVOGENE CO., LTD.    223
TABLE 197    NOVOGENE CO., LTD.: BUSINESS OVERVIEW    223
12.1.12    ZYMO RESEARCH CORPORATION    225
TABLE 198    ZYMO RESEARCH CORPORATION: BUSINESS OVERVIEW    225
12.1.13    TECAN TRADING AG    227
TABLE 199    TECAN TRADING AG: BUSINESS OVERVIEW    227
FIGURE 40    TECAN TRADING AG: COMPANY SNAPSHOT (2020)    228
12.1.14    INTEGRAGEN SA    230
TABLE 200    INTEGRAGEN SA: BUSINESS OVERVIEW    230
FIGURE 41    INTEGRAGEN SA: COMPANY SNAPSHOT (2020)    230
12.1.15    MICROSYNTH AG    232
TABLE 201    MICROSYNTH AG: BUSINESS OVERVIEW    232
12.1.16    DNASTAR, INC.    234
TABLE 202    DNASTAR: BUSINESS OVERVIEW    234
12.2    OTHER COMPANIES    235
12.2.1    COSMOSID, INC.    235
TABLE 203    COSMOSID, INC.: COMPANY OVERVIEW    235
12.2.2    GENEXA AG    236
TABLE 204    GENEXA AG.: COMPANY OVERVIEW    236
12.2.3    VARIGEN BIOSCIENCES CORPORATION    236
TABLE 205    VARIGEN BIOSCIENCES: COMPANY OVERVIEW    236
12.2.4    VERITAS GENETICS    237
TABLE 206    VERITAS GENETICS: COMPANY OVERVIEW    237
12.2.5    SINGENE    237
TABLE 207    SINGENE: COMPANY OVERVIEW    237
12.2.6    METAGENOMI    238
TABLE 208    METAGENOMI: COMPANY OVERVIEW    238
12.2.7    COMPUTOMICS    238
TABLE 209    COMPUTOMICS: COMPANY OVERVIEW    238
12.2.8    IDBYDNA, INC.    239
TABLE 210    IDBYDNA, INC.: COMPANY OVERVIEW    239
12.2.9    INTACT GENOMICS, INC.    239
TABLE 211    INTACT GENOMICS, INC. COMPANY OVERVIEW    239
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13    APPENDIX    240
13.1    DISCUSSION GUIDE    240
13.2    KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    244
13.3    AVAILABLE CUSTOMIZATIONS    246
13.4    RELATED REPORTS    246
13.5    AUTHOR DETAILS    247"